Subject Areas on Research
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
- Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction.
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients.
Keywords of People